Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - SYNERGY PHARMACEUTICALS, INC.Financial_Report.xls
10-Q - 10-Q - SYNERGY PHARMACEUTICALS, INC.a14-19725_110q.htm
EX-32.1 - EX-32.1 - SYNERGY PHARMACEUTICALS, INC.a14-19725_1ex32d1.htm
EX-31.2 - EX-31.2 - SYNERGY PHARMACEUTICALS, INC.a14-19725_1ex31d2.htm
EX-31.1 - EX-31.1 - SYNERGY PHARMACEUTICALS, INC.a14-19725_1ex31d1.htm

EXHIBIT 32.2

 

CERTIFICATION OF SENIOR VICE PRESIDENT, FINANCE
SYNERGY PHARMACEUTICALS INC.
FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2014
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

I am the Senior Vice President, Finance of Synergy Pharmaceuticals Inc., a Delaware corporation (the “Company”). I am delivering this certificate in connection with the Form 10-Q of the Company for the quarter ended September 30, 2014 and filed with the Securities and Exchange Commission (“Form 10-Q”).

 

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I hereby certify that, to the best of my knowledge, the Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Date: November 10, 2014

/s/ BERNARD F. DENOYER

 

Bernard F. Denoyer

 

Senior Vice President, Finance

 

1